2,657
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Legumain/pH dual-responsive lytic peptide–paclitaxel conjugate for synergistic cancer therapy

, , , , , , & ORCID Icon show all
Pages 1764-1775 | Received 23 Mar 2022, Accepted 16 May 2022, Published online: 31 May 2022